Asthma Clinical Study

Peanut Allergy

About this Clinical Study

About this Clinical Study

Asthma is a chronic condition that causes inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, chest tightness and shortness of breath.

Although many people manage asthma with inhalers and medication, a significant number of patients still experience ongoing symptoms and flare-ups that impact daily life.

Globally, asthma affects hundreds of millions of people and remains an important area of medical research aimed at improving long-term disease control.

This clinical study is evaluating a potential new treatment designed to target airway inflammation associated with asthma.

By participating in this study, volunteers will help researchers better understand how this treatment may improve asthma outcomes in the future.

Researchers are currently recruiting adults with asthma to participate in a clinical study evaluating a potential new treatment designed to reduce airway inflammation and improve asthma control.

If you have asthma and regularly use inhaler medication, you may be eligible to participate.

Learn More

Who Can Take Part?

Who Can Take Part?

You may be eligible to take part if you:

Are 18 to 65 years old
Have doctor-diagnosed Asthma
Currently use asthma medication such as inhalers
Are able to attend multiple clinic visits over several months
Haven’t used oral steroid tablets for your asthma in the past 2 months
Have had asthma symptoms within the past year

You cannot take part if you:

You cannot take part if you:

  • You do not currently have doctor-diagnosed asthma

    • You have needed steroid tablets recently for asthma flare-ups

    • Your asthma medication has changed in the past few months

    • You have another serious respiratory condition

    • You are currently taking certain specialist medications

    • Are unable to commit to the required clinic visits and follow-up

    Final eligibility is determined by the study doctor after screening assessments.

Final eligibility is determined by the study doctor after screening assessments.

Learn More

What’s Involved

What’s Involved

If you take part, your involvement may include:

An initial screening period to confirm eligibility

Receive the study treatment or placebo

Attend regular clinic visits for monitoring

Complete lung function tests and health assessments

Regular follow-up visits, blood tests, and health checks

Remain in the study for several months

This study runs for approximately 9 months, including screening, treatment, and follow-up appointments.

Participants will attend scheduled clinic visits throughout the study so the research team can monitor health, asthma symptoms, and response to treatment.

The exact number and timing of visits will be explained during screening.

Learn More